fred turner

T2 · manager / operator

Fred Turner is a UK-born founder who moved to Silicon Valley at 19. He built Curative from a COVID testing startup (7 to 7,000 employees, $5B revenue) into a $1.3B-valued health insurance company leveraging AI agents. He co-founded Subcritical, a nuclear energy company commercializing accelerator-driven subcritical fission (energy amplifier).

17 calls·17 names·41% bull·last heard 24 days ago·20VC
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$SUBCRITICALSubcriticalposition

Subcritical pursues energy amplifier nuclear fission with particle accelerator for inherent safety

Subcritical is commercializing the energy amplifier concept (accelerator-driven subcritical fission) which operates at 0.97 criticality — physically incapable of runaway reaction — enabling faster regulatory approval and deployment than traditional nuclear, targeting 300MW facilities at ~$1B construction cost.

20VC2026-07
2ndhigh conviction
$CURATIVECurativeposition

Curative pivots from $5B COVID testing to AI-driven health insurance at $1.3B valuation

Curative is leveraging its pandemic-scale operations expertise and AI agents to disrupt the health insurance market by automating back-office workflows (credentialing, claims, underwriting, network contracting) and aligning incentives toward preventive care, targeting the $1.5T US employer healthcare spend.

20VC2026-07
3rdhigh conviction
$CRMSalesforce

Curative cancels $600k/yr Salesforce contract, replaces with internal AI-built CRM in 2 months

Salesforce and similar SaaS platforms are being displaced by internal AI-built tools that integrate natively with agent workflows, cost less, and eliminate dedicated admin headcount — Curative built a replacement in 2 months that works better for their processes.

20VC2026-07

most discussed · click a bar to filter

17 total
$BLUE-CROSS
Blue Cross Blue Shield
MEDfred turner·20VC·24 days ago
Blue Cross consolidation creates negotiating inefficiencies AI-native insurers can exploit
Ultra-consolidated payer markets (4 major players) create bilateral monopolies with hospital systems that inflate costs; AI-native entrants can undercut on admin expense (9% → near-zero) without needing equivalent scale.
"What's happened is you have these massive payers like the market is ultra consolidated. You basically have like four large players that control the entire market on the payer side…"
39:05
$DGX
···
Quest Diagnostics
MEDfred turner·20VC·24 days ago
Quest and LabCorp's efficiency-optimized model fails under pandemic surge demand
Traditional lab incumbents (Quest, LabCorp) are built for steady-state efficiency (1% margin gains) and cannot scale 10x rapidly during demand surges because their supply chains, automation, and culture are optimized for stability not elasticity.
"What did you see that others didn't? That you have to kind of scale like something like that up from scratch that the existing labs like the lab industry in general is a very low…"
27:08
$CRM
···
Salesforce
HIGHfred turner·20VC·24 days ago
Curative cancels $600k/yr Salesforce contract, replaces with internal AI-built CRM in 2 months
Salesforce and similar SaaS platforms are being displaced by internal AI-built tools that integrate natively with agent workflows, cost less, and eliminate dedicated admin headcount — Curative built a replacement in 2 months that works better for their processes.
"We just recently canceled our Salesforce contract because we have an internal CRM that was built, you know, was vibe coded, that is working better, that is managing our process be…"
45:54
$LOOKER
···
Looker (Google)
MEDfred turner·20VC·24 days ago
Curative migrates off Looker to Snowflake using AI agents, cutting year-long project to months
Traditional BI tools like Looker are being replaced by AI-assisted migrations to modern data stacks (Snowflake) where agents automate dashboard conversion and data restructuring, reducing engineering effort from years to months.
"We moved away from Looker um right Google's Looker product for visualizations. It's super expensive. Um and we moved to do it in Snowflake um and it's been a lot cheaper. It's wor…"
64:07
$RO
Ro
LOWfred turner·20VC·24 days ago
Ro spent hundreds of millions on failed sepsis diagnostics — graveyard of capital-intensive diagnostics
Large capital investments in sepsis diagnostics (Ro, Siemens) failed because better tests don't help if community hospitals lack staff to suspect sepsis early — the bottleneck is clinical workflow, not test accuracy.
"A bunch of big pharma companies like Ro spent a couple hundred million. Um Seaman spent a hundred million. A bunch of companies spent a lot of money trying to make better sepsis d…"
15:10
$A16Z
Andreessen Horowitz
LOWfred turner·20VC·24 days ago
a16z bio fund seeded first company (TL Biolabs/Shield) without TAM analysis
a16z's bio fund invested $1.65M in cattle testing company based on founder potential rather than market size — the company later pivoted to human diagnostics after Series A investors did TAM math.
"We went to YC and we raised a seed round from Andre a seed round from Andre. Yeah, their their bio uh fund uh did our seed round right out of YC. Um and I don't think they did the…"
6:57
$JOSH-BUCKLEY
Josh Buckley
LOWfred turner·20VC·24 days ago
Josh Buckley first check into Curative during YC, backed founder despite UK background
Early founder-backed investing (Josh Buckley) overcame geographic bias — invested in YC batch company despite founder's UK origin and lack of traditional credentials, illustrating Silicon Valley's advantage over UK ecosystem.
"The guy Josh Buckley who, you know, was one of the first in guys who invested in us during the YC batch just because he liked what we were doing and he thought it was it was cool.…"
86:48
$JUSTIN-MATINE
Justin Matine
MEDfred turner·20VC·24 days ago
Justin Matine first investor in Curative at $3M valuation, got 10x return via dividend
Early conviction backing of founder (invested $125k at $3M pre) paid off — Curative returned 10x capital via dividend before insurance pivot, and investors retained equity for $1.3B valuation round.
"Justin was the first investor you mentioned at the beginning Justin Matine. Uh he came in uh right as I was shutting down Shield. He was an investor in Shield. Um and he wanted to…"
17:52
$UNH
···
UnitedHealth Group
MEDfred turner·20VC·24 days ago
Consolidated payers like UnitedHealth face structural margin pressure from AI-native competitors
Large incumbents (UnitedHealth, Blue Cross) cannot rapidly adopt AI agents due to organizational inertia — laying off 50k people to capture AI margins takes a decade, while AI-native insurers like Curative can deploy agents immediately and compete on lower admin costs.
"I think some of the biggest insurers will struggle because they they will not be able to keep up from a margin standpoint with where we can get to with agents. I think some of the…"
49:17
$SNOW
···
Snowflake
MEDfred turner·20VC·24 days ago
Snowflake gains as Curative migrates from Looker for cheaper, AI-friendly analytics
Snowflake benefits from enterprises moving off legacy BI stacks and leveraging its platform for AI-agent-driven data transformation and visualization workflows.
"We moved away from Looker um right Google's Looker product for visualizations. It's super expensive. Um and we moved to do it in Snowflake um and it's been a lot cheaper. It's wor…"
64:07